Sticks and Stones
April 1, 2020
An injectable drug could help heal broken bones faster
1 min read
Mar
The Battle Against the Brain-Eating Amoeba
March 31, 2020
How can nanoparticles be used to prevent deaths caused by unicellular organisms?
1 min read
Manufacture
Contract Manufacturing Services
Business Practice
Outsourcing
Technology & Manufacturing
Business & Trends
Outsourcing on the Rise
March 28, 2020
En vogue and in demand, the industry’s reliance on CDMOs is growing
1 min read
Manufacture
Advanced Medicine
Analytical Science
Bioprocessing - Upstream & Downstream
Bioprocessing - Single Use Systems
Cell & Gene
Bioprocessing
Biopharma
Advanced Medicine: Replicating the mAb Success Story
March 27, 2020
What lessons has the industry learned from the manufacture of monoclonal antibodies? And how can these help us face the challenges presented by viral vector production for cell and gene therapies?
1 min read
Business & Regulation
Business Practice
Advanced Medicine
Analytical Science
Bioprocessing - Upstream & Downstream
Small Molecules
Technology and Equipment
Business & Trends
Cell & Gene
Bioprocessing
Biopharma
Small Molecules
Facilities & Equipment
Technology & Manufacturing
One Vision, One Culture, One Team
March 26, 2020
Sitting Down With… Mike McMullen, President and CEO, Agilent Technologies, Santa Clara, California, USA
1 min read
Business & Regulation
Business Practice
Technology and Equipment
Business & Trends
Facilities & Equipment
Technology & Manufacturing
Digitalization Now
March 25, 2020
Digital technologies are here – but are they being used adequately?
1 min read
A Word of Advice
March 24, 2020
Looking to set up your own company but lacking business acumen? Help is at hand
1 min read
What Lessons Have We Learned from Ebola?
March 24, 2020
And how can we ensure we are better prepared to develop new vaccines and treatments for future infectious disease outbreaks?
1 min read
Achieving Excellence
March 24, 2020
Sitting Down With… Tom Moody, VP of Technology Development and Commercialization at Almac, Craigavon, UK.
1 min read
Accepting Responsibility for Global Health
March 23, 2020
Morningside Pharmaceuticals, a UK company based in Leicestershire, develops generic medicines, but has also been supplying global aid for almost 30 years. The company works through the private sector, ministries of health, and with large aid agencies, such as UNICEF, WHO, MSF and the Red Cross. As a seasoned exporter of medical supplies to global aid organizations, Morningside demonstrates that pharmaceutical companies can make a big difference by donating drugs to the developing world. We speak with Nik Kotecha, CEO of Morningside, to discuss why pharma companies have a responsibility to take the lead.
1 min read
Browse by Topics
Interview
Drug Discovery
Development & Clinical
Formulation
Drug Delivery
Bioprocessing
Small Molecules
Cell & Gene
Facilities & Equipment
Outsourcing
Packaging
Supply Chain
Regulation & Standards
Industry News
Research News
Sitting Down With
Innovation Awards
Business & Trends
Technology & Manufacturing
Biopharma
Future of Pharma
Latest
Blog